Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Chemicals Industry Analysis

UpdatedJul 14, 2026
DataAggregated Company Financials
Companies5
  • 7D-1.1%
  • 3M12.8%
  • 1Y-9.2%
  • YTD10.2%

Over the last 7 days, the Chemicals industry has dropped 1.1%, driven by a pullback from Sika of 7.4%. Meanwhile, EMS-CHEMIE HOLDING actually outperformed within the industry, gaining 8.2% in the last week. Overall the industry is down 9.2% in 12 months. Looking forward, earnings are forecast to grow by 8.2% annually.

Industry Valuation and Performance

Has the Swiss Chemicals Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 14 Jul 2026CHF 77.4bCHF 24.9bCHF 2.4b29.5x31.6x3.1x
Thu, 11 Jun 2026CHF 71.9bCHF 24.9bCHF 2.4b27.2x29.4x2.9x
Sat, 09 May 2026CHF 67.0bCHF 24.9bCHF 2.4b23.9x27.4x2.7x
Mon, 06 Apr 2026CHF 63.7bCHF 24.9bCHF 2.4b23.4x26x2.6x
Wed, 04 Mar 2026CHF 68.9bCHF 24.9bCHF 2.4b25.5x28.6x2.8x
Fri, 30 Jan 2026CHF 67.2bCHF 25.4bCHF 2.8b22.8x24.3x2.6x
Sun, 28 Dec 2025CHF 70.0bCHF 25.4bCHF 2.8b24.1x25.3x2.8x
Tue, 25 Nov 2025CHF 70.4bCHF 25.4bCHF 2.8b24.1x25.4x2.8x
Thu, 23 Oct 2025CHF 77.1bCHF 25.6bCHF 2.8b26x27.6x3x
Sat, 20 Sep 2025CHF 75.5bCHF 25.6bCHF 2.8b25.8x27x2.9x
Mon, 18 Aug 2025CHF 78.1bCHF 25.7bCHF 2.9b26.4x27.3x3x
Wed, 16 Jul 2025CHF 85.1bCHF 25.8bCHF 3.0b29x28.2x3.3x
Fri, 13 Jun 2025CHF 90.5bCHF 25.8bCHF 3.0b29.5x30.1x3.5x
Sun, 11 May 2025CHF 87.2bCHF 25.8bCHF 3.0b28.2x29x3.4x
Tue, 08 Apr 2025CHF 77.3bCHF 25.8bCHF 3.0b25.8x25.7x3x
Thu, 06 Mar 2025CHF 93.5bCHF 25.8bCHF 3.0b31.6x31x3.6x
Sat, 01 Feb 2025CHF 92.8bCHF 25.8bCHF 2.9b32.8x31.8x3.6x
Mon, 30 Dec 2024CHF 89.2bCHF 25.5bCHF 2.9b31.1x31.2x3.5x
Wed, 27 Nov 2024CHF 90.8bCHF 25.5bCHF 2.9b31.8x31.7x3.6x
Fri, 25 Oct 2024CHF 98.5bCHF 25.6bCHF 2.8b34.5x34.7x3.9x
Sun, 22 Sep 2024CHF 104.4bCHF 25.6bCHF 2.8b33.8x36.7x4.1x
Tue, 20 Aug 2024CHF 101.5bCHF 25.7bCHF 2.8b36.1x35.7x4x
Thu, 18 Jul 2024CHF 102.9bCHF 25.2bCHF 2.6b36.7x39.7x4.1x
Sat, 15 Jun 2024CHF 102.5bCHF 25.2bCHF 2.6b37.4x39.6x4.1x
Mon, 13 May 2024CHF 104.9bCHF 25.2bCHF 2.6b39.3x40.5x4.2x
Wed, 10 Apr 2024CHF 100.7bCHF 25.2bCHF 2.5b40.2x40.5x4x
Fri, 08 Mar 2024CHF 96.2bCHF 25.2bCHF 2.5b39.5x37.9x3.8x
Sun, 04 Feb 2024CHF 90.5bCHF 25.7bCHF 2.2b37x41x3.5x
Tue, 02 Jan 2024CHF 99.6bCHF 26.1bCHF 2.3b36.9x44x3.8x
Thu, 30 Nov 2023CHF 90.0bCHF 26.1bCHF 2.3b34.7x39.7x3.5x
Sat, 28 Oct 2023CHF 83.7bCHF 26.1bCHF 2.3b31.7x37x3.2x
Mon, 25 Sep 2023CHF 87.0bCHF 25.7bCHF 2.2b33.5x39.1x3.4x
Wed, 23 Aug 2023CHF 86.2bCHF 25.8bCHF 2.3b34.3x37x3.3x
Fri, 21 Jul 2023CHF 91.4bCHF 26.0bCHF 2.5b34.2x36.9x3.5x
Price to Earnings Ratio

36.9x


Total Market Cap: CHF 91.4bTotal Earnings: CHF 2.5bTotal Revenue: CHF 26.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Chemicals Industry Price to Earnings3Y Average 33.1x202420252026
Current Industry PE
  • Investors are relatively neutral on the Swiss Chemicals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 33.1x.
  • The industry is trading close to its 3-year average PS ratio of 3.4x.
Past Earnings Growth
  • Both revenue and earnings for companies in the Chemicals industry have remained mostly flat over the last three years.
  • This means that sales and the cost of doing business have remained relatively consistent over this period and subsequently, so have profits.

Industry Trends

Which industries have driven the changes within the Swiss Materials industry?

CH Market-0.45%
Materials-2.96%
Chemicals-1.12%
Specialty Chemicals-1.12%
Industry PE
  • Investors are most optimistic about the Specialty Chemicals industry, which is trading close to its 3-year average PE ratio of 33.1x.
    • Analysts are expecting annual earnings growth of 8.2%, which is higher than its past year's earnings decline of 1.7% per year.
  • Investors are most pessimistic about the Specialty Chemicals industry, which is trading close to its 3-year average of 33.1x.
Forecasted Growth
  • Analysts are most optimistic on the Specialty Chemicals industry, expecting annual earnings growth of 8.2% over the next 5 years.
  • This is better than its past earnings decline of 1.7% per year.
  • In contrast, the Specialty Chemicals industry is expected to see its earnings grow by 8.2% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EMSN EMS-CHEMIE HOLDINGCHF 762.5010.1%
+CHF 1.6b		20.9%PE38.2x
CLN ClariantCHF 7.927.8%
+CHF 189.1m		-9.1%PS0.7x
GURN Gurit HoldingCHF 37.702.7%
+CHF 4.7m		137.1%PS0.6x

Latest News

EMSN
CHF 762.50
EMS-CHEMIE HOLDING
7D
10.1%
1Y
20.9%
SIKA
CHF 158.65
Sika
7D
-7.2%
1Y
-22.4%
Narrative Update • Jul 08

SIKA: Neutral Rating Shift And Facility Expansion May Support Repricing

Analysts have nudged the fair value estimate for Sika higher, from CHF 180.69 to CHF 187.82. They cite slightly firmer revenue growth assumptions, a marginally lower discount rate, and updated P/E expectations that reflect the recent series of price target increases to around CHF 161 to CHF 165 alongside the shift to more neutral ratings.
GURN
CHF 37.70
Gurit Holding
7D
2.7%
1Y
137.1%
Narrative Update • Jul 06

GURN: Optimistic Revenue And Margin Assumptions Will Likely Keep Shares Overvalued

Analysts have raised their price target for Gurit Holding to CHF 29.21 from CHF 23.21, citing updates to fair value estimates, discount rate assumptions, revenue growth expectations, profit margin forecasts, and a revised future P/E multiple. What’s in the News for Gurit Holding No recent news items for Gurit Holding were identified in the provided sources.
GIVN
CHF 3,383.00
Givaudan
7D
-4.3%
1Y
-9.8%
Narrative Update • Jun 25

GIVN: Pricing Power And AI Beauty Push Will Shape Future Margin Resilience

Givaudan's analyst fair value estimate has been adjusted modestly higher to CHF 3,468 from CHF 3,415, reflecting analysts' updated assumptions for slightly stronger revenue growth, a similar discount rate, a broadly unchanged profit margin profile, and a small increase in expected future P/E multiples, alongside a recent series of price target revisions across the Street that now cluster in the CHF 2,900 to CHF 3,500 range. Analyst Commentary Recent research on Givaudan points to a mixed but generally constructive view, with several firms adjusting price targets in a relatively tight CHF 2,900 to CHF 3,500 band and a blend of rating upgrades and downgrades.
CLN
CHF 7.92
Clariant
7D
7.8%
1Y
-9.1%
Narrative Update • Jun 23

CLN: Pricing Power And Specialty Focus Will Drive Re Rating Potential

Clariant's analyst price target has been revised lower by CHF 1.40 to reflect a recalibrated fair value, with analysts citing recent cuts to CHF 7.50 from Deutsche Bank and Citi, as well as more balanced views from Goldman Sachs at CHF 8.50 and JPMorgan at CHF 9.30, as they reassess the stock's quality profile, pricing power and valuation. Analyst Commentary Recent research on Clariant points to a mixed but increasingly constructive tone, with several bullish analysts highlighting improving quality perceptions and a more supportive view on valuation.